Patent US4435388A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4435388A Expired / Lapsed US ⏱️ 0.0 years remaining

Tylosin 20-imino-20-deoxo-4"-acyl derivatives, pharmaceutical compositions and method of use

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1982-06-10
•
Granted: 1984-03-06
•
Expires: 2002-06-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are disclosed 20-imino-20-deoxo-4''-acyl derivatives of the antibiotic tylosin which have higher serum levels and better absorption than the parent tylosins. Methods of preparation of the compounds are also disclosed.

Inventors

  • 👤 Ashit K. Ganguly
  • 👤 Allan K. Mallams
  • 👤 Yi-Tsung Liu

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 18:34
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08

Claims Analysis

Total Claims: 47
Claim 1
Independent Claim 257 words
A compound of the formula ##STR10## wherein R 1 is hydrogen or an acyl group selected from alkanoyl of 2 to 5 carbon atoms, palmityl, stearyl, lauryl, oleyl, chloroacetyl, benzoyl, adamantanecarbonyl, cyclopropanecarbonyl, cyclohexanecarbonyl, β-cyclohexylpropionyl, phenylacetyl, phenoxyacetyl, mandelyl, 2-thienylacetyl, alkyl-, aryl- and aralkylsulfonyl, substituted aryl- and aralkylsulfonyl, wherein the substituents on the aryl portions are halogen, nitro and alkoxy groups, succinyl, maleyl, fumaryl, malonyl and phthalyl; R 2 is acyl, wherein acyl is as defined in R 1 ; R 3 is hydrogen or acyl, wherein acyl is as defined in R 1 ; or R 2 and R 3 are together a carbonyl group linking the 3"-and 4"-hydroxyl groups; R 4 is hydrogen or acyl, wherein acyl is as defined in R 1 ; R 5 is selected from the group consisting of ##STR11## wherein n is 0-2, and Q is selected from the gorup consisting of CH 2 , CR 6 R 7 , CHR 6 , CHR 7 , NH,NR 6 , O, S, SO 2 , CHOH, CHOR 6 , CHOR 7 , ##STR12## CHCOOH, CHCOOR 6 , CHCONH 2 , and CHCONR 6 R 7 , wherein R 6 and R 7 may be the same or different each being a member of the group consisting of (C 1-C 6 )alkyl, (C 7-C 10 )aralkyl and (C 6-C 10 )aryl including X-substituted aryl and aralkyl, wherein X is halogen, trifluoromethyl, (C 1-C 6 ) alkoxy, or (C 1-C 6 ) alkylcarbonyl; N--NH--aralkyl, and ##STR13## and the non-toxic pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 257 words
A compound of the formula ##STR10## wherein R 1 is hydrogen or an acyl group selected from alkanoyl of 2 to 5 carbon atoms, palmityl, stearyl, lauryl, oleyl, chloroacetyl, benzoyl, adamantanecarbonyl, cyclopropanecarbonyl, cyclohexanecarbonyl, β-cyclohexylpropionyl, phenylacetyl, phenoxyacetyl, mandelyl, 2-thienylacetyl, alkyl-, aryl- and aralkylsulfonyl, substituted aryl- and aralkylsulfonyl, wherein the substituents on the aryl portions are halogen, nitro and alkoxy groups, succinyl, maleyl, fumaryl, malonyl and phthalyl; R 2 is acyl, wherein acyl is as defined in R 1 ; R 3 is hydrogen or acyl, wherein acyl is as defined in R 1 ; or R 2 and R 3 are together a carbonyl group linking the 3"-and 4"-hydroxyl groups; R 4 is hydrogen or acyl, wherein acyl is as defined in R 1 ; R 5 is selected from the group consisting of ##STR11## wherein n is 0-2, and Q is selected from the gorup consisting of CH 2 , CR 6 R 7 , CHR 6 , CHR 7 , NH,NR 6 , O, S, SO 2 , CHOH, CHOR 6 , CHOR 7 , ##STR12## CHCOOH, CHCOOR 6 , CHCONH 2 , and CHCONR 6 R 7 , wherein R 6 and R 7 may be the same or different each being a member of the group consisting of (C 1-C 6 )alkyl, (C 7-C 10 )aralkyl and (C 6-C 10 )aryl including X-substituted aryl and aralkyl, wherein X is halogen, trifluoromethyl, (C 1-C 6 ) alkoxy, or (C 1-C 6 ) alkylcarbonyl; N--NH--aralkyl, and ##STR13## and the non-toxic pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 16 words
A compound according to claim 1 wherein R 5 is a group of the formula ##STR14##
Claim 4
Dependent Claim 37 words
A compound according to claim 1 or 2 wherein R 1 , R 3 and R 4 are hydrogen and R 2 is an acyl group selected from the group consisting of acetyl, propionyl, n-butyryl and iso-valeryl.
Claim 5
Dependent Claim 38 words
A compound according to claim 1 or 2 wherein R 1 is acetyl, R 3 and R 4 are hydrogen and R 2 is an acyl group selected from the group consisting of acetyl, propionyl, n-butyryl and iso-valeryl.
Claim 6
Dependent Claim 36 words
A compound according to claim 1 or 2 wherein R 1 and R 3 are hydrogen and R 2 and R 4 are acyl groups selected from the group consisting of acetyl, propionyl, n-butyryl and iso-valeryl.
Claim 7
Dependent Claim 36 words
A compound according to claim 1 or 2 wherein R 1 and R 4 are hydrogen, and R 2 and R 3 are acyl groups selected from the group consisting of acetyl, propionyl, n-butyryl and iso-valeryl.
Claim 8
Dependent Claim 36 words
A compound according to claim 1 or 2 wherein R 1 is hydrogen and R 2 , R 3 and R 4 are acyl groups selected from the group consisting of acetyl, propionyl, n-butyryl and iso-valeryl.
Claim 9
Dependent Claim 19 words
A compound according to claim 1 or 2 wherein R 2 and R 3 are a bridging carbonyl group.
Claim 10
Dependent Claim 9 words
The compound according to claim 2 which is 20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 11
Dependent Claim 10 words
The compound according to claim 2 which is 4"-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl) -imino]tylosin.
Claim 12
Dependent Claim 10 words
A compound according to claim 2 which is 2', 4"-di-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)-imino]tylosin.
Claim 13
Dependent Claim 9 words
A compound according to claim 2 which is 2'-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)-imino]-4"-O-iso-valeryltylosin.
Claim 14
Dependent Claim 9 words
A compound according to claim 2 which is 4'-O-n-butyryl-20-deoxo-20[(4,4-dioxothiomorpholinyl)-imino]-3"-O-propionyltylosin.
Claim 15
Dependent Claim 9 words
A compound according to claim 2 which is 2'-O-acetyl-4"-O-n-butyryl-20-deoxo-20-[(4,4-dioxo-thiomorpholinyl)imino]-3"-O-propionyltylosin.
Claim 16
Dependent Claim 9 words
A compound according to claim 2 which is 3"-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorphilinyl)-imino]-4"-O-iso-valeryltylosin.
Claim 17
Dependent Claim 10 words
A compound according to claim 2 which is 2', 3"-di-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)-imino]-4"-O-iso-valeryltylosin.
Claim 18
Dependent Claim 10 words
A compound according to claim 2 which is 3", 4"-O-carbonyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)-imino]tylosin.
Claim 19
Dependent Claim 10 words
A compound according to claim 2 which is 2'-O-acetyl-3",4"-O-carbonyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl) imino]-tylosin.
Claim 20
Dependent Claim 1 words
20-deoxo-20-[(4,4-dioxothiomorpholinyl)-imino]-tylosin.
Claim 21
Dependent Claim 1 words
20-deoxo-20-[(4,4-dioxothiomorpholinyl)-imino]-tylosin.
Claim 22
Dependent Claim 33 words
A method of eliciting an antibactrial response in a mammal having a gram positive bacterial infection which comprises administering to the mammal a therapeutically effective quantity of a compound according to claim 1.
Claim 23
Dependent Claim 11 words
A method according to claim 20 wherein R 5 is ##STR15##
Claim 24
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 4"-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]tylosin.
Claim 25
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 20-deoxy-20-[(4,4-dioxothiomorpholinyl)-inino]4"-O-iso-valeryltylosin.
Claim 26
Dependent Claim 13 words
A method according to claim 21 wherein the compound utilized is 2', 4"-di-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]tylosin.
Claim 27
Dependent Claim 11 words
A method according to claim 21 wherein the compoundutilized is 2'-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 28
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 4"-O-n-butyryl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-3"-O-propionyltylosin.
Claim 29
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 2'-O-acetyl-4"-O-n-butyryl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-3"-O-propionyltylosin.
Claim 30
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 3"-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 31
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 2',3"-di-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 32
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 3",4"-O-carbonyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-tylosin.
Claim 33
Dependent Claim 12 words
A method according to claim 21 wherein the compound utilized is 2'-O-acetyl-3",4"-O-carbonyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-tylosin.
Claim 34
Dependent Claim 39 words
A pharmaceutical composition adapted for the treatment of a mammal having a gram positive bacterial infection which comprises a therapeutically effective quantity of a compound according to claim 1 or 2 in admixture with a pharmaceutically acceptable carrier therefor.
Claim 35
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 4"-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-tylosin.
Claim 36
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 37
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 2',4"-di-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-tylosin.
Claim 38
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 2'-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 39
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 4"-O-n-butyryl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-3"-O-propionyltylosin.
Claim 40
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 2'-O-acetyl-4"-O-n-butyryl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-3"-O-propionyltylosin.
Claim 41
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 3"-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 42
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 2',3"-di-O-acetyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-4"-O-iso-valeryltylosin.
Claim 43
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 3",4"-O-carbonyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-tylosin.
Claim 44
Dependent Claim 10 words
A pharmaceutical composition according to claim 32 which comprises 2'-O-acetyl-3",4"-O-carbonyl-20-deoxo-20-[(4,4-dioxothiomorpholinyl)imino]-tylosin.
Claim 45
Dependent Claim 11 words
A pharmaceutical composition according to claim 32 adapted for oral administration.
Claim 46
Dependent Claim 11 words
A pharmaceutical composition according to claim 32 adapted for topical composition.
Claim 47
Dependent Claim 11 words
A pharmaceutical composition according to claim 32 adapted for injectable administration.

References Cited (Backward Citations)

US4268665A Cited
GB2077730A Cited
GB2077731A Cited
US4279896A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-03-06 1987-09-05 1988-03-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-03-06 1991-09-05 1992-03-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-03-06 1995-09-05 1996-03-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag